Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$1.22B |
| 3 |
Chevron
CVX
|
+$477M |
| 4 |
Pfizer
PFE
|
+$375M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.58B |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.28B |
| 3 |
Schwab International Equity ETF
SCHF
|
+$4.53B |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.13B |
| 5 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$2.63B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 10.58% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Mirion Technologies
MIR
$3.9B
| $17.3M | ﹤0.01% |
1,559,576
+38,474
| +3% | +$405K |
|
1777
Integra LifeSciences
IART
$1.39B
| $17.2M | ﹤0.01% |
944,282
+125,620
| +15% | +$2.91M |
|
1778
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $17.1M | ﹤0.01% |
429,394
-1,186
| -0.3% | -$49.6K |
|
1779
Navient
NAVI
$830M
| $17M | ﹤0.01% |
1,092,270
+19,606
| +2% | +$302K |
|
1780
Intellia Therapeutics
NTLA
$1.5B
| $17M | ﹤0.01% |
827,545
+37,714
| +5% | +$870K |
|
1781
Amphastar Pharmaceuticals
AMPH
$892M
| $17M | ﹤0.01% |
350,056
-9,166
| -3% | -$402K |
|
1782
UL Solutions
ULS
$15.8B
| $16.9M | ﹤0.01% |
342,707
+117,794
| +52% | +$5.73M |
|
|
RYZ
1783
Ryerson Holding Corp
RYZ
$1.46B
| $16.9M | ﹤0.01% |
847,514
+203,314
| +32% | +$4.11M |
|
1784
AMC Entertainment Holdings
AMC
$2.39B
| $16.9M | ﹤0.01% |
3,705,500
+2,243,052
| +153% | +$11.2M |
|
1785
Alkami Technology
ALKT
$2.01B
| $16.9M | ﹤0.01% |
534,375
+120,845
| +29% | +$3.81M |
|
1786
Argan
AGX
$8.31B
| $16.8M | ﹤0.01% |
165,528
-18,432
| -10% | -$1.46M |
|
1787
Novavax
NVAX
$1.26B
| $16.7M | ﹤0.01% |
1,325,508
+187,548
| +16% | +$2.42M |
|
1788
NeoGenomics
NEO
$2.09B
| $16.7M | ﹤0.01% |
1,134,651
+57,677
| +5% | +$902K |
|
1789
Dana Inc
DAN
$2.97B
| $16.7M | ﹤0.01% |
1,584,817
+56,626
| +4% | +$624K |
|
|
AIV
1790
Aimco
AIV
$387M
| $16.7M | ﹤0.01% |
1,842,853
+44,668
| +2% | +$397K |
|
1791
Marten Transport
MRTN
$1.22B
| $16.6M | ﹤0.01% |
940,431
+38,990
| +4% | +$684K |
|
1792
Vertex
VERX
$2.17B
| $16.6M | ﹤0.01% |
432,068
+23,086
| +6% | +$851K |
|
1793
Lindsay Corp
LNN
$1.15B
| $16.6M | ﹤0.01% |
132,952
+5,007
| +4% | +$601K |
|
1794
FirstService
FSV
$6.31B
| $16.6M | ﹤0.01% |
90,541
-2,748
| -3% | -$472K |
|
1795
Brighthouse Financial
BHF
$3.55B
| $16.5M | ﹤0.01% |
367,407
-512
| -0.1% | -$23K |
|
1796
Westamerica Bancorp
WABC
$1.39B
| $16.5M | ﹤0.01% |
334,297
+22,902
| +7% | +$1.16M |
|
|
VRNT
1797
DELISTED
Verint Systems
VRNT
| $16.5M | ﹤0.01% |
651,741
+7,409
| +1% | +$228K |
|
1798
MP Materials
MP
$8.45B
| $16.5M | ﹤0.01% |
935,007
-300,874
| -24% | -$4.09M |
|
1799
Braze
BRZE
$2.89B
| $16.5M | ﹤0.01% |
509,767
+57,713
| +13% | +$2.28M |
|
|
PENG
1800
Penguin Solutions Inc
PENG
$2.96B
| $16.5M | ﹤0.01% |
786,634
+23,781
| +3% | +$512K |
|
Similar funds
Charles Schwab's Q3 2024 Portfolio in Review
As of Q3 2024, Charles Schwab held 3,658 positions worth $524B, down 0.18% from $525B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab withdrew a net $33.1B in Q3 2024, closing 156 positions and reducing 1,005 holdings. Its most notable exit was Schwab US Large- Cap ETF, an estimated $9.58B position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Charles Schwab opened a new position in Shopify worth $194M.
- Charles Schwab's largest Q3 2024 buy was Shopify: 2,416,436 shares worth $194M.
- Charles Schwab added most to Apple in Q3 2024, an estimated $1.32B increase.
- Charles Schwab's biggest Q3 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $958M.
- Charles Schwab fully exited Schwab US Large- Cap ETF in Q3 2024, selling an estimated $9.58B.
- Charles Schwab's ten largest holdings make up 21% of its $524B portfolio in Q3 2024.
- Charles Schwab opened 39 new positions and closed 156 in Q3 2024.
- Charles Schwab's portfolio value fell 0.18% quarter-over-quarter to $524B.
Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.